Kinarus Therapeutics Holding AG (XSWX:KNRS) COGS-to-Revenue : 0.00 (As of Dec. 2021)

View and export this data going back to 1999. Start your Free Trial

What is Kinarus Therapeutics Holding AG COGS-to-Revenue?

Kinarus Therapeutics Holding AG's Cost of Goods Sold for the six months ended in Dec. 2021 was CHF0.00 Mil. Its Revenue for the six months ended in Dec. 2021 was CHF0.00 Mil.

Kinarus Therapeutics Holding AG's COGS to Revenue for the six months ended in Dec. 2021 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Kinarus Therapeutics Holding AG's Gross Margin % for the six months ended in Dec. 2021 was N/A%.

Kinarus Therapeutics Holding AG COGS-to-Revenue Historical Data

The historical data trend for Kinarus Therapeutics Holding AG's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kinarus Therapeutics Holding AG COGS-to-Revenue Chart

Kinarus Therapeutics Holding AG Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

COGS-to-Revenue

Get a 7-Day Free Trial

0.89

0.97

0.96

Kinarus Therapeutics Holding AG Semi-Annual Data
	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21
COGS-to-Revenue	Get a 7-Day Free Trial															0.95	0.97	-	-	-

Kinarus Therapeutics Holding AG COGS-to-Revenue Calculation

Kinarus Therapeutics Holding AG's COGS to Revenue for the fiscal year that ended in Dec. 2021 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Kinarus Therapeutics Holding AG's COGS to Revenue for the quarter that ended in Dec. 2021 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Kinarus Therapeutics Holding AG (XSWX:KNRS) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Kinarus Therapeutics Holding AG's Gross Margin % for the six months ended in Dec. 2021 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Kinarus Therapeutics Holding AG COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Kinarus Therapeutics Holding AG's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Kinarus Therapeutics Holding AG (XSWX:KNRS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Transportation » Kinarus Therapeutics Holding AG (XSWX:KNRS) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

3, Avenue de Florimont, Lausanne, CHE, CH-1006

Website

https://www.perfect.aero

Perfect Holding SA is a Switzerland-based company that focuses on the acquisition and management of investments in companies, which are active in the aircraft management and related services sector. The company operates in one business segment which includes Charters. The products provided by the company include Aircraft sales, Charter sales, and Aircraft consultancy.

Kinarus Therapeutics Holding AG (XSWX:KNRS) Headlines

No Headlines